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difﬁcult. In traditional clinical trials challenges to completeness
and accuracy of cost data and protocol-induced bias may reduce
generalizability of results. “Real-world” trials are potentially
useful but few have been conducted. With readily available
claims data, the practical approach is to use cost-to-charge ratio
to estimate the dollar value of consumed resources. This paper
examines the characteristics and cost-to-charge ratio for CABG
patients by hospital and department over time. METHODS:
Premier data for 17,000 CABG patients from 187 US hospitals
between 2002 and 2004 were used. Hospital cost-to-charge
ratios were estimated with patient level total cost and charges at
discharge and within each department. Cost-to-charge ratio by
hospital type and location were assessed. RESULTS: Cost-
to-charge ratios were not associated with hospital bed size
although from 2002 to 2004, the ratios decreased ranging from
2% to 14% percent indicating improved efﬁciency for all hos-
pitals. The cost-to-charge ratio disparity between teaching and
non-teaching hospitals is shrinking over time (0.43 vs. 0.40 and
0.39 vs. 0.38 at year 2002 and 2004, respectively). The cost-to-
charge ratio gap between urban and rural hospitals remains over
time (0.48 vs. 0.40 at year 2002, 0.46 vs. 0.37 at year 2004).
With regard to departmental cost-to-charge ratio, they differ
greatly by hospital department and vary across hospitals. Except
for anesthesia, for teaching hospitals departmental cost-to-
charge ratios declined on average by 14% (4% to 28%) from
2002 to 2004. For non-teaching hospitals, changes over time
were mixed. For urban hospitals, departmental cost-to-charge
ratios had declining patterns similar to that of teaching hospi-
tals. CONCLUSIONS: Cost-to-charge ratio for CABG patients
varies by hospital type and these differences declined over time.
Appropriate cost-to-charge ratios must be used in order to
produce valid cost estimates.
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OBJECTIVES: First, estimate the prevalence of diet/nutrition
(DN) and exercise counseling (EC) in patients with dyslipidemia
during ambulatory care visits in the United States. Secondly,
compare the likelihood of receiving DN or EC across various
patient and physician characteristics. METHODS: The National
Ambulatory Medical Care Survey (NAMCS) data for 2000 and
2001 were merged to obtain cross-sectional nationwide estimates
of DN and EC. Dyslipidemia patients were identiﬁed by ICD-9
codes (272.XX). Sampling weights were provided by the
NAMCS and logistic regressions were used. RESULTS: A total
of 29.6 million (2-year average) visits in the U.S. had a diagno-
sis of dyslipidemia (n = 1620). Provision of DN was greater than
EC (37% and 25%, respectively). Men were statistically signiﬁ-
cantly more likely to receive DN and EC than women, after
adjusting for race and age (OR = 1.2 and 1.3, respectively). After
adjusting for race and gender, subjects aged 50–64 years were
more likely to receive DN than any other age group and subjects
aged 30–49 were more likely to receive EC than any other age
group. Compared to whites, blacks were 30% and 10% more
likely to receive DN and EC, respectively, after adjusting for age
and gender. It was found that self-paying subjects were more
likely to receive EC (OR = 1.2, p = 0.003) but less likely to
receive DN (OR = 0.72, p = 0.0002) than subjects with private
insurance. Physicians located in the West provided greater pro-
visions of DN and EC when compared to physicians located in
other parts of the United States (OR = 2.2 and 1.5, respectively).
Compared to internists or cardiologists, family medicine physi-
cians provided more DN and EC (p < 0.0001). CONCLUSION:
Over two years, provisions of DN and EC were relatively low.
More efforts in providing these preventative measures are 
warranted.
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OBJECTIVES: To predict high-risk patients with cardiovascular
disease (CVD) over a 1, 2, and 3 year time period. Good pre-
diction models will enable health care providers to target high
risk patients who would most beneﬁt from intervention pro-
grams designed to improve CVD patient outcomes. METHODS:
Using classiﬁcation and regression tree (C&RT) analysis from
AnswerTree (SPSS 3.0), risk models were developed using 
California Medicaid (Medi-Cal) medical and pharmaceutical
claims data for 62,154 patients with a diagnosis of CVD. Vari-
ables deﬁned for the 6-month pre-period were used to predict
year 1, year 2, and year 3 total costs. To determine the predic-
tive ability of the model, we designated high cost patients as
those with total costs of greater than $10,000, and low cost
patients as those with less than $10,000. RESULTS: Outpatient
cost (of approximately $3600, >1 SD above the median) in the
six months prior to diagnosis was the most common split. Other
contributing factors were patient comorbidities, including Other
Neurological Disorders (p < 0.01), Deﬁciency Anemias (p <
0.01), and Hypertension (p < 0.01). Results for years 2 and 3
were similar to year 1 ﬁndings. With further examination of the
data, we found that the small group of high cost patients at Year
1 continue to be high cost patients in the subsequent years,
although nearly 14.5% drop out at year 2 and 14.5% dropout
from year 2 to year 3. 35% of the sample was correctly grouped
into the high-cost branch, while 98% of the low-cost subjects
were correctly grouped into the low-cost branch. CONCLU-
SIONS: C&RT is a useful method in predicting high risk
patients. As demonstrated in this sample, patients incurring high
costs were signaled through outpatient utilization, and were cor-
rectly identiﬁed with a sensitivity of 35% and a speciﬁcity of
98%.
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OBJECTIVE: The Expected Value of Perfect Information (EVPI)
is becoming an increasing valuable tool to assist healthcare deci-
sion makers with their choices of new healthcare technologies.
Although the use of EVPI in healthcare decision making is on
the rise the study of its properties has received little attention.
This study will evaluate the properties of the EVPI in the context
of a currently published model for a cholesterol lowering
therapy. METHODS: The properties of the EVPI were studied
using a Markov chain model that evaluated the cost-effective-
ness of ezetimibe co-administration with statin therapy vs statin
titration (Cook et al. 2004). Simulations of the model were run
for iterations of size 1000, 10,000 and 100,000. Baseline deci-
sions were evaluated for blocks of 1000 iterations and the
percent of correct optimal decisions as well as the mean and stan-
dard deviation for the net beneﬁts were tabulated within each
block. RESULTS: The estimated EVPI for 1000, 10,000 and
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100,000 iterations were $19,696, $21,617 and $21,648 respec-
tively. Based on the estimated mean and standard deviations of
net beneﬁts for each treatment group we estimated that 11,325
iterations would be necessary to provide stables estimates of the
EVPI for this example. Additional theoretical calculations show
that the EVPI has a positive bias in small samples and is depen-
dent on the probability of choosing the wrong treatment in any
given iteration. CONCLUSION: A positive bias exists in the
EVPI estimates for smaller number of iterations. This bias can
be overcome by using sample size calculations to determine the
appropriate number of iterations. The appropriate number of
iterations will eliminate the chance of making the wrong base-
line decision.
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OBJECTIVES: A number of different methods have been
employed by investigators to calculate adherence estimates for
patients taking lipid-lowering therapy (LLT), including measures
with different numerator and denominator options. Although at
least one method is known to correlate well with cardiovascular
outcomes, most have not been evaluated in outcomes studies.
The purpose of this analysis was to evaluate the different
methods and determine whether there are correlations between
them. METHODS: Adherence ratios were calculated using dif-
ferent methods for n = 12,448 managed-care patients who were
considered new starts with statin therapy. The different measures
calculated were compared and tested for differences and corre-
lations. Proportions of patients who would be categorized as
“adherent” using each method, according to a threshold of 0.8,
were also determined and compared for differences. RESULTS:
Adherence ratios calculated with like denominators did not vary
substantially, regardless of which numerator method was used.
Those calculated with different denominators had substantial
variability. The proportion of patients who would be categorized
as “adherent” or “non-adherent” differed between the methods
for about one-third of patients. CONCLUSIONS: Studies of
adherence with statin therapy should be interpreted with caution
depending on which denominator option is used. Further
research is needed to determine which methods correlate best
with patient outcomes such as reductions in LDL-C and cardio-
vascular events.
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OBJECTIVES: This study aims to validate the Taiwan version
of treatment-related quality of life questionnaire for patients
receiving oral anticoagulation. A comparison was also made
between this questionnaire and Taiwan version RAND 36-Item
Health Survey 1.0. METHODS: The treatment-related quality of
life questionnaire was translated into Chinese from its English
version developed by Dr. Sawicki and its wording and meaning
were modiﬁed based on the recommendations of two Taiwan
experts. The 32 items of the treatment-related quality of life
questionnaire covered the following psychological domains:
medical treatment satisfaction, self-efﬁcacy, strained social
network, daily hassles, and general psychological distress. Physi-
cians at outpatient department referred patients receiving oral
anticoagulation treatment to anticoagulation clinic. Both treat-
ment-related quality of life questionnaire and Taiwan version
RAND 36-Item Health Survey 1.0 (RAND-36) were adminis-
trated to them in the ﬁrst visit time and at 4-month follow-up.
The internal reliability coefﬁcient of the questionnaire (Cronbach
alpha) was assessed in this study. RESULTS: A total of 114
patients receiving oral anticoagulation treatment were referred
to anticoagulation clinic. The treatment-related questionnaire
and RAND-36 Survey were completed by 78 patients both at
baseline and 4-month follow-up. The response rate was 68.4%
(78/114). In validation study, the medical treatment satisfaction
domains of treatment-related questionnaire were correlated
moderately with mental health domain (r = 0.53), and energy
domain (r = 0.44) of Taiwan version RAND-36. The daily hassles
domains were also correlated moderately with Social function-
ing domain (r = 0.41), mental health domain (r = 0.55), and
energy domain (r = 0.47) of Taiwan version RAND-36. The
Cronbach’s alphas were 0.52 to 0.80 in assessing internal con-
sistency of each domain of the treatment-related questionnaire.
The corrected item total-correlations ranged from 0.20 to 0.72.
CONCLUSIONS: This Taiwan version questionnaire is a reliable
and valid instrument for evaluating the treatment-related quality
of life for patients receiving oral anticoagulation.
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OBJECTIVES: Many quality improvement research projects rely
on abstraction of medical record data. Therefore, the objective
of this study was to create and adapt an electronic medical record
abstraction tool to collect data of hypertensive patients from a
Community Hospital. METHODS: A team of three physicians’
experts in clinical research and two researchers identiﬁed the
domains of interest for the project. They listed the main items
by domain. The electronic medical record abstraction tool was
created and then, multiple tests were carried out to cross-check
domains/items with information already recorded in ﬁve medical
charts. Three abstractors were trained and a data dictionary for
abbreviations was created. To validate the tool, 16 medical
records of patients were reviewed independently by 2 medical
abstractors who did not have a clinical background. The data
abstracted were analyzed for inter-rater reliability. Face to face
validity was assessed by a group of three physicians to improve
the tool, data abstraction, and to document the proﬁciency of
the abstractors to assure data quality. RESULTS: Forty one
medical records have been reviewed using the tool. The average
interrater reliability rate was 92%. Average age of abstractors
was 23 years and 2 of them had college degree. Most of the infor-
mation requested by the abstraction tool was recorded on
medical charts. CONCLUSIONS: Standardized protocols to
review and create tools for reviewing medical charts should be
implemented. Efforts should be done to adapt those tools to spe-
ciﬁc research settings when completing abstractions.
